Status:
COMPLETED
Effect of Broccoli Sprout Extract in Patients With Chronic Kidney Disease With Diabetes Type 2
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Lantmännen
Conditions:
Chronic Kidney Disease Stage 3B
Chronic Kidney Disease stage4
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This research project aims to test if sulforaphane, administered as broccoli sprout extract (BSE) can ameliorate glucose control in adult patients with chronic kidney disease (CKD) and DM 2 with GFR \...
Eligibility Criteria
Inclusion
- Patients with a GFR 15-45 ml/min/1.73 m2, DM type 2, age \>18 years old, able to read and understand Swedish.
Exclusion
- Use of metformin, use of warfarin, levels of ASAT, ALAT more than three times the upper limit at screening or at any subsequent visit, kidney transplantation, inflammatory bowel disease, celiac disease, malignant diseases (except skin basalioma) in the previous 3 years, and any other condition that the treating doctor believes is contraindicated; allergy to broccoli; participation in another clinical trial which may affect the outcome of the present study; not to understand the study information.
Key Trial Info
Start Date :
October 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 18 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04858854
Start Date
October 10 2021
End Date
May 18 2023
Last Update
March 4 2024
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Gävle Hospital
Gävle, Sweden, 80187
2
Sahlgrenska Universitetssjukhuset
Gothenburg, Sweden, 41345
3
Linköpings universitet
Linköping, Sweden, 58183
4
Skånes University Hospital Sus
Lund, Sweden, 22185